Guerbet (GBT) EUR1

Sell:€15.70Buy:€15.90€0.02 (0.13%)

Prices delayed by at least 15 minutes
Sell:€15.70
Buy:€15.90
Change:€0.02 (0.13%)
Deal now
Prices delayed by at least 15 minutes
Sell:€15.70
Buy:€15.90
Change:€0.02 (0.13%)
Prices delayed by at least 15 minutes
Deal now

Company Information

About this company

Guerbet SA is a France-based pharmaceutical group specialized in the manufacture and marketing of medical imaging contrast agents destined for diagnostic purposes. It produces medical imaging contrast products for x-ray imaging, magnetic resonance imaging (MRI), ultrasound imaging and for nuclear medicine. The contrast agents are used in the diagnosis of cardio-vascular, inflammatory and neuro-degenerative disorders. The Company’s portfolio of products comprises brands, such as Xenetix, Hexabrix, Optiray, Oxilan, Telebrix, Lipiodol, Dotarem, Endorem, Artirem, Lumirem, and Lipiodol, among others. Guerbet SA is also active in the fine chemicals industry through its Simafex subsidiary. The Company operates through its subsidiaries, including Simafex, Medex, SCI KALB, Guerbet LLC, Guerbet Asie Pacifique and Guerbet GmbH, among others.

Key people

Jerome Estampes
Interim Chief Executive officer, Chief Financial Officer, SVP - Administration, Finance, and IT, Business Development and Licensing, Member of the Executive Committee
Philippe Bourrinet
Deputy Chief Executive Officer, Senior Vice President - Development, Medical & Regulatory Affairs, Chief Pharmacist, Member of the Executive Committee
Valerie Brissart
Senior Vice President - Diagnostic Imaging, Marketing Director, Member of the Executive Committee
Eva Ohlsson
Senior Vice President - Human Resources, Corporate Social Responsibility, Member of the Executive Committee
Christine Allard
Senior Vice President - Public Affairs and Communications, Member of the Executive Committee
Charlotte Bamiere
Senior Vice President - Legal Affairs and Compliance, Member of the Executive Committee
Raoul Bernhardt
Senior Vice President - Industrial Operations, CSR & HSE, and Procurement, Member of the Executive Committee
Francois Nicolas
Senior Vice President - Research, Development, Innovation and AI, Chief Digital Officer, Member of the Executive Committee
Eric Kummer
Senior Vice President - Technical Operations
Hugues Lecat
Independent Chairman of the Board
Carine Dagommer
Director
Marie de La Simone
Director, Representative of Employees
Eric Guerbet
Director
Celine Lamort
Director
Click to see more

Key facts

  • Shares in issue
    12.64m
  • EPIC
    GBT
  • ISIN
    FR0000032526
  • Location
    France
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • Market cap
    €200.99m
  • Employees
    2,905
  • Exchange
    Euronext Paris
  • Index
  • Website
    Visit website

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.